The ATTR amyloidosis treatment market is estimated to be valued at USD 4.14 Bn in 2025 and is expected to reach USD 7.52 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2032. https://hallbook.com.br/blogs/744864/ATTR-Amyloidosis-Treatment-Market-Accelerates-with-Innovative-Therapeutics